Markets open

IDEXX Laboratories, Inc.

IDXX · NASDAQ-GS

Analyst Consensus

Buy

13 analysts

$586

Current

—

Low

$745

Average

—

High

Average target implies +27.11% versus the current price.

The ratings synthesis for IDXX has not been generated yet.

Rating Actions

No individual rating actions have been captured for IDXXyet. Consensus figures above come from Nasdaq's aggregate feed.

Rating actions are extracted from published reporting. Each row links to its source.

Covering Firms

B OF A GLBL RES

BARCLAYS CAPITA

CLEVELAND RESEA

CO FORECST

EXANE BNP PARIB

GOLDMAN SACHS

JP MORGAN SECUR

MORGAN STANLEY

PIPER SANDLER

ROTHSCHILD REDB

STIFEL NICOLAUS

WILLIAM BLAIR

ZACKS RESEARCH

Symbol: IDXX
Type: Stock
Sector: Health Care
Industry: Biotechnology: In Vitro & In Vivo Diagnostic Substances
Country: North America
Exchange: NASDAQ-GS

IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions-to advance medical care, improve efficiency, and build thriving practices. Our innovations also help measure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500 Index. Headquartered in Maine, IDEXX employs approximately 11,000 people and offers solutions and products to customers in more than 175 countries and territories. For more information about IDEXX, visit www.idexx.com.